Stay updated on PRM-151 Efficacy in IPF Clinical Trial
Sign up to get notified when there's something new on the PRM-151 Efficacy in IPF Clinical Trial page.

Latest updates to the PRM-151 Efficacy in IPF Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has removed significant details about a Phase 2 clinical trial for PRM-151 in treating Idiopathic Pulmonary Fibrosis (IPF), including the study's design, inclusion and exclusion criteria, and the name of the study director. A new revision number has been added.SummaryDifference22%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to PRM-151 Efficacy in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PRM-151 Efficacy in IPF Clinical Trial page.